BRPI0907797B8 - uso de 3,3'-diindolilmetano, laticínios, doces e/ou confeitos para a prevenção, tratamento e/ou retardo da perda auditiva relacionada ao envelhecimento - Google Patents

uso de 3,3'-diindolilmetano, laticínios, doces e/ou confeitos para a prevenção, tratamento e/ou retardo da perda auditiva relacionada ao envelhecimento

Info

Publication number
BRPI0907797B8
BRPI0907797B8 BRPI0907797A BRPI0907797A BRPI0907797B8 BR PI0907797 B8 BRPI0907797 B8 BR PI0907797B8 BR PI0907797 A BRPI0907797 A BR PI0907797A BR PI0907797 A BRPI0907797 A BR PI0907797A BR PI0907797 B8 BRPI0907797 B8 BR PI0907797B8
Authority
BR
Brazil
Prior art keywords
diindolylmethane
aging
prevention
delay
treatment
Prior art date
Application number
BRPI0907797A
Other languages
English (en)
Inventor
Musselr Bernd
Raederstorff Daniel
Hug Hubert
Wang-Schmidt Ying
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0907797A2 publication Critical patent/BRPI0907797A2/pt
Publication of BRPI0907797B1 publication Critical patent/BRPI0907797B1/pt
Publication of BRPI0907797B8 publication Critical patent/BRPI0907797B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

novo uso de 3,3' -diindolilmetano. trata-se do uso de dim e/ou seus derivados para a prevenção, tratamento e/ou retardo da perda auditiva relacionada ao envelhecimento em mamíferos.
BRPI0907797A 2008-02-19 2009-02-19 uso de 3,3'-diindolilmetano, laticínios, doces e/ou confeitos para a prevenção, tratamento e/ou retardo da perda auditiva relacionada ao envelhecimento BRPI0907797B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08003002 2008-02-19
PCT/EP2009/051959 WO2009103755A1 (en) 2008-02-19 2009-02-19 Novel use of 3,3'-diindolylmethane

Publications (3)

Publication Number Publication Date
BRPI0907797A2 BRPI0907797A2 (pt) 2015-07-14
BRPI0907797B1 BRPI0907797B1 (pt) 2019-12-03
BRPI0907797B8 true BRPI0907797B8 (pt) 2021-05-25

Family

ID=40580855

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907797A BRPI0907797B8 (pt) 2008-02-19 2009-02-19 uso de 3,3'-diindolilmetano, laticínios, doces e/ou confeitos para a prevenção, tratamento e/ou retardo da perda auditiva relacionada ao envelhecimento

Country Status (8)

Country Link
US (1) US8420677B2 (pt)
EP (1) EP2242491B1 (pt)
JP (1) JP5407079B2 (pt)
CN (1) CN101945656B (pt)
BR (1) BRPI0907797B8 (pt)
ES (1) ES2390815T3 (pt)
PL (1) PL2242491T3 (pt)
WO (1) WO2009103755A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130086143A (ko) * 2010-04-28 2013-07-31 가부시키가이샤산와카가쿠켄큐쇼 내이장애의 예방 또는 치료약
CN102327262A (zh) * 2011-10-08 2012-01-25 合肥博太医药生物技术发展有限公司 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗糖尿病药物中的应用
WO2013120107A1 (en) * 2012-02-09 2013-08-15 University Of Rochester Methods and compositions for treating a subject to inhibit hearing loss
KR101392177B1 (ko) 2012-12-17 2014-05-08 한국식품연구원 다이인돌리메탄을 유효성분으로 함유하는 후각과민증 예방 및 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129225B2 (en) * 2001-10-22 2006-10-31 The Research Foundation Of State University Of New York Protection against and treatment of hearing loss
US7074938B2 (en) * 2002-11-19 2006-07-11 The Regents Of The University Of California Method for the synthesis of soritin compounds
WO2005089412A2 (en) * 2004-03-17 2005-09-29 Takemoto Arnold C Tissue detoxification and health supplements and methods of making and using them
US20060100264A1 (en) * 2004-11-06 2006-05-11 Bjeldanes Leonard F 3,3'-Diindolylmethane immune activating compositions
EP1838303B1 (en) 2004-12-30 2011-02-09 Bioresponse LLC Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
CN100378073C (zh) * 2005-12-29 2008-04-02 中国海洋大学 二吲哚基甲烷及其制备方法

Also Published As

Publication number Publication date
EP2242491A1 (en) 2010-10-27
US8420677B2 (en) 2013-04-16
EP2242491B1 (en) 2012-07-11
PL2242491T3 (pl) 2012-12-31
CN101945656A (zh) 2011-01-12
JP5407079B2 (ja) 2014-02-05
BRPI0907797A2 (pt) 2015-07-14
WO2009103755A1 (en) 2009-08-27
BRPI0907797B1 (pt) 2019-12-03
US20110190367A1 (en) 2011-08-04
JP2011514888A (ja) 2011-05-12
CN101945656B (zh) 2014-06-11
ES2390815T3 (es) 2012-11-16

Similar Documents

Publication Publication Date Title
MX343322B (es) Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel.
WO2006081182A3 (en) Antibacterial agents
WO2007118130A3 (en) Antibacterial agents
WO2006081289A3 (en) Antibacterial agents
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
WO2006081178A3 (en) Antibacterial agents
TW200608985A (en) Method and compositions useful for preventing and/or treating sensitive and/or dry skin
WO2005079143A3 (en) Topical formulations for the treatment of skin conditions
MY184985A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2004087145A3 (en) Antibacterial agents
BRPI0511615B8 (pt) forma de administração oral compreendendo bactéria probiótica
MX2010005986A (es) Productos de grano que tienen un edulcorante natural potente y un agente de volumen.
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
AU2003291227A1 (en) Antibacterial agents
MX2008002598A (es) Metodos para aplicar formulaciones antimicrobianas en alimento.
WO2007016610A3 (en) Antibacterial agents
MY147247A (en) Organic compounds and their uses
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
WO2008031798A3 (en) Edible wafer products produced by extrusion
WO2004018461A3 (en) Antibacterial benzoic acid derivatives
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
ATE534398T1 (de) Munddesinfektionsmittel und nahrungsmittelzusatz mit diesem desinfektionsmittel
ATE486604T1 (de) Prophylaktisches/therapeutisches mittel für abweichungen im fettstoffwechsel
AU2003303956A1 (en) Antibacterial agents

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/404 (2006.01), A23L 2/52 (2006.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/12/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/12/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/02/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF